Biocides
The regulations in force (EU, national and UK) in the biocidal products sector require very complex activities, ranging from preliminary evaluation of the formulation, to efficacy and risk assessment, up to the preparation of dossiers.
If you have any doubts regarding the regulation and the concerning guidelines/standards or how to implement them, our experts can help you.
Feasibility studies include:
– Preliminary analysis of your product (is it BPR or borderline product?)
– Project preliminary design
– Experimental plan
– SOCs, EDCs and relevant regulatory milestones
– Business Plan of the regulatory project
BPR one-stop-solution Dossier Management including:
– Consultancy activity
– Risk Assessment
– Experimental Study Monitoring
– Dossier Preparation, Submission and Post-submission
– Communication with Authorities
Design and description of the family approach upon CA-July19-Doc.4.2-Final – Guidance note on BPF concept: assessment of similarity in BPF by:
– Similarity of composition upon each component hazard assessment
– Similarity of Uses
– Similar levels of risk
– Similar level of efficacy
Toxicological and Risk assessment of:
– Substance of Concerns (SOCs)
– Endocrine Disruptive Chemicals (EDCs)
– Persistent Bioaccumulative and Toxicological substances (PBTs)
– Notification, registration and/authorization procedures in European Countries (PMC, SIMMBAD, Real Decreto, HSE notification, etc)
– Communication with Authorities
The step-by-step procedure to achieve Art95 compliance, including:
– Experimental studies for Technical Equivalence / Chemical Similarity
– Regulatory support / liaison for Letter of Access achievement
– Submissions and communication with Authorities
While Chemsafe has no internal laboratory, we can assist you during the testing phase thanks to our vast and versatile network and partnerships for:
– Chemical and stability studies
– Efficacy tests on different Product Types
– Safety endpoints
Chemsafe’s Task Force Management experience and innovative approach as a good balance between costs sharing and companies agile business strategies.